|Day Low/High||23.21 / 23.73|
|52 Wk Low/High||14.34 / 27.64|
Jim Cramer explains the unexpected: quarterly results are 'not as bad as feared' -- NABAF. It's boosting stocks that, based on the headlines, should really just crumple.
This discounted value and the potential benefits of the merger/integration catalyst is why we continue view this stock as a hold despite its recent struggles.
Jim shares his view of how club members should approach the trade talks, he discusses an analyst downgrade of UnitedHealth Group, and much more!
The Networking for Autonomous Vehicles (NAV) Alliance, announced that Marvell (NASDAQ: MRVL) is joining the NAV Alliance as a promoter following the completion of its recent acquisition of Aquantia Corp.
Cramer says with these unrelenting trade pressures, investors shouldn't do anything outrageous, anything fancy. They should hold tight and wait for when China isn't so in the balance.
Jim Cramer takes a look at Roku, Gilead Sciences, HEXO, Rambus, Canopy Growth, Kroger, Costco.
Shares of chipmaker Marvell Technology fall after Needham removes the semiconductor maker from its conviction list, replacing it with Vicor.
We do not think today's news changes Marvell's 5G catalyst story or the recovery the company has seen in storage.
Enhanced 32GFC accelerates NVMe access with 50% more IOPS and lower latency
A volatile week ends with heightened expectations for at least one more rate cut from the Fed.
The chipmaker rises after Stifel analyst Tore Svanberg assumes coverage of the stock with a buy rating and 12-month price target of $29.
Markets buffeted by impeachment turmoil and shift away from high-multiple growth names.
Barclays analysts aren't dissuaded by Marvell's disappointing quarterly guidance, issued in late August.
Delivers high-quality automotive software with secure and reliable next generation Ethernet solutions for mission critical applications
High bandwidth automotive solutions support greater data aggregation with advanced routing and superior security capabilities
Markets traded mostly flat this week in spite of Saudi oil attacks, and a Fed rate cut, only turning sour on Friday on signs of renewed U.S. trade tensions with China.
Tomorrow's interest-rate decision is still viewed as a toss-up.
Easing trade tensions and steepening yield curve add to bulls' optimism.
A trade deal still seems far away, so check your China exposure, again, as earnings season approaches.
But whether the Chinese will make concessions will remains to be seen. So far, they have not given an inch, and they have the most to lose.
Jim Cramer says politicians, media and government agencies may be taking aim at the tech giants, but consumers still love them and their products.
Jim Cramer weighs in on Pilgrim's Pride, Rio Tinto, Sarepta Therapeutics, MGP Ingredients, Occidental Petroleum and more.
Marvell Technology, Nvidia and Lam Research were all in the green.
Stocks fell on manufacturing worries, but snapped back by the end of the week on renewed hopes for easing U.S.- China trade tensions.
One group that rallies the hardest on positive trade headlines is the semis, and we have terrific exposure to the group through our big investments, including Lam Research.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.